NRX Pharmaceuticals NRXP
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 3.30 | 68.30 | -0.20 | -4,023 | -6 | |
| 2025Q2 | 3.26 | 21.22 | -0.98 | -3,730 | -18 | |
| 2025Q1 | 2.05 | 69.79 | -0.34 | -3,847 | -6 | |
| 2024Q4 | 2.20 | 26.79 | -0.77 | -2,432 | -9 | |
| 2024Q3 | 1.69 | 186.20 | -0.10 | -3,022 | -2 | |
| 2024Q2 | 2.44 | 89.27 | -0.75 | -7,050 | -8 | |
| 2024Q1 | 4.72 | 95.24 | -0.74 | -5,998 | -7 | |
| 2023Q4 | 4.60 | 103.62 | -0.50 | -4,406 | -4 | |
| 2023Q3 | 2.60 | 96.45 | -0.67 | -5,808 | -6 | |
| 2023Q2 | 4.84 | 93.93 | -1.15 | -8,188 | -9 | |
| 2023Q1 | 6.59 | 85.47 | -1.66 | -9,435 | -11 | |
| 2022Q4 | 11.10 | 96.52 | -1.50 | -9,888 | -10 | |
| 2022Q3 | 7.40 | 100.65 | -1.30 | -9,142 | -9 | |
| 2022Q2 | 6.00 | 137.50 | -1.10 | -9,600 | -7 | |
| 2022Q1 | 24.50 | 116.81 | -2.10 | -15,705 | -13 | |
| 2021Q4 | 47.80 | 174.23 | -5.30 | -52,975 | -30 | |
| 2021Q3 | 92.70 | 54.26 | -3.50 | -20,099 | -37 | |
| 2021Q2 | 116.20 | 106.96 | -3.90 | -17,116 | -16 | |
| 2021Q1 | 26.40 | -7.10 | -236 | -1 | ||
| 2020Q4 | 96.92 | -13.10 | 5,357 | 6 |